Document is current
Any future updates will be listed below
-
Authors
Wang, Yao
Wang, Xiao-Ming
Huo, Da
Wang, Shi-Bo
Liu, Qian-Yi
Pang, Jing
Shen, Tao
Cui, Di
Zhao, Wen-Juan
Luo, Qing-Feng
Li, Nan
Chen, Ai-Qun
Cui, Ju
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32271501)
National Natural Science Foundation of China (81770228)
Shenzhen Science and Technology Plan Platform and Carrier Special Project (ZDSYS20220303153551001)
National High Level Hospital Clinical Research Funding (BJ-2024-219)
- License Information
-
More Information
Article History
Received: 6 December 2025
Accepted: 24 May 2026
First Online: 28 June 2026
Declarations
:
: Part of the experimental data in this study was obtained from Shanghai OUTDO Biotech Co., Ltd. and approved by its Ethics Committee (Approval No.: SHYJS-CP-1707003). In addition, publicly available and fully de-identified data from The Cancer Genome Atlas (TCGA) were used, and all analyses complied with the human subject protection and data access policies outlined by the National Cancer Institute and NHGRI (January 2014). All data were analyzed in accordance with relevant ethical standards and data-use policies to ensure compliance, safety, and traceability throughout the research process.
: The authors declare no competing interests.
: Not applicable.
